Projeto
BMX-targeted ligand-drug conjugates for prostate cancer therapy
| Referência: | 702428 |
|---|---|
| Programa de financiamento: | H2020 |
| Organização financiadora: | European Commission |
| Instituições associadas: | Universidade de Lisboa |
Registos relacionados
TRPV1-targeted ligand-drug conjugates to treat prostate cancer
Modulation and targeting of calcium channels with ligand-drug conjugates for cancer therapy
A Small Molecule Drug Conjugate SMDC for Prostate Cancer Therapy
DRUG DELIVERY: DEVELOPMENT OF TARGETED FUNCTIONAL PARTICLES FOR CANCER THERAPY
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
Targeting metastatic breast cancer with innovative ruthenium-peptide conjugates
Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer
EVALUATION OF THE IMPORTANCE OF ANTI-DLL4 THERAPY IN A MURINE MODEL OF PROSTATE CANCER
Design of iminoboronate based antitumor targeting conjugates
TARGETING SIGNALING PATHWAYS AS THERAPY FOR HUMAN CANCER
Small molecule cytokine conjugates for cancer treatment
Role of E-selectin ligands in breast cancer metastasis
Nucleolin targeting by G-quadruplex aptamers for cervical cancer therapy
Nucleolin targeting by G-quadruplex aptamers for cervical cancer therapy
Targeting the proteasome in anticancer therapy by a computational based drug discovery approach
Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)
Targeting Rac1-signaling to enhance iodide-related cancer therapy
Development of novel antibody-drug conjugated molecules for treatment of B-cell malignancies
RUNNING away from prostate cancer: WALKING through the molecular basis of physical activity
Doctoral Program in Bioengineering - Cell Therapies and Regenerative Medicine - Translating Breast Cancer Immune Features Into Targeted Therapies
Photosensitizer/biomaterial local drug delivery systems with potential application in photodynamic therapy of cancer
Local drug delivery systems based on biodegradable nanofibers for cancer photodynamic therapy PDT
An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Drug repurposing from cancer therapy to control of infections [PTDC/BIA-MIC/5343/2020]
DRUG DISCOVERY FOR p53 PPI-TARGETS
DRUG DISCOVERY FOR p53 PPI-TARGETS
DESIGN AND DEVELOPMENT OF PPARDELTA SELECTIVE LIGANDS USING STRUCTURE BASED AND LIGAND BASED COMPUTATIONAL APPROACHES
TherMelVac- dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
Targeting cancer with ruthenium compounds
Targeting cancer with ruthenium compounds
Unrevealing the effect of STEAP1 knockdown in prostate cancer cells: from protein expression profile to clinical applications
NOVEL DRUG/GENE DELIVERY PLATFORMS BASED ON THE SELF-ASSEMBLY OF DENDRIMER-SINGLE STRAND DNA CONJUGATES
Innovative therapies and technologies in cancer
RANK-pathway as a mediator of resistance to cyclin inhibitors and HER2-targeted therapies in breast cancer
Aquaporins in metabolic syndrome:new targets for drug discovery
New drugs to target Neurodegenerattion and Neuroinflammation in Parkinson ´s Disease
Bolsa de Doutoramento FCT: Androgens/anti-androgens and glycaemia in reprogramming metabolism of prostate cancer: targeting both androgen receptor and metabolism as a therapeutic option [SFRH/BD/111351/2015]
Multitarget-directed ligand strategy for Alzheimers disease
Nucleolin targeting by G-quadruplex aptamers for cervical cancer therapy [IF/00959/2015/CP1300/CT0002]
Local drug delivery systems based on biodegradable nanofibers for cancer photodynamic therapy PDT [SFRH/BD/147517/2019]
Publicações relacionadas
Carregando publicações...